TREM1 and neoplasm: They demonstrated the overexpression of TREM-1 in tumors and determined the close correlation between TREM-1 and unfavorable outcomes, the infiltration of immune-suppressive cells, and immune regulation, highlighting TREM-1′s potential use as a tumor prognostic biomarker and a novel target for immunotherapy.